Skip to main content
Top
Published in: Trials 1/2018

Open Access 01-12-2018 | Study protocol

Effectiveness and safety of acupuncture for elderly overactive bladder population in Hong Kong: study protocol for a randomized controlled trial

Authors: Yu Tat Chan, Hong Wei Zhang, Yuan Qi Guo, Tony Ngai Ho Chan, Yiu-Keung Kwan, Chun-Kam Lee, Kit Ngan, Zhi-Xiu Lin

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

Overactive bladder (OAB) is defined as “urgency, with or without urge incontinence, usually with frequency and nocturia”. Acupuncture is one of the most popular alternative treatment methods for OAB. Little established evidence is available to support the effectiveness of acupuncture for OAB. This study is a pioneer randomized, double-blinded, sham-controlled trial to assess the effectiveness and safety of acupuncture in the elderly population with overactive bladder in Hong Kong.

Methods/design

This is a randomized, double-center, patient and outcome assessor blinded, sham-controlled trial. The study sample size is 100 patients. Eligible subjects aged between 60 to 90 years old will be recruited into this study. All subjects will be randomly allocated into the active acupuncture group or sham acupuncture group in a 1: 1 ratio. Participants who are allocated into the active acupuncture group will receive a standardized 30-min real acupuncture treatment session for a total of 16 sessions on the top of standard routine care, whilst those who are randomized to the sham acupuncture arm will receive sham acupuncture in addition to standard routine care. Non-penetrating needles will be utilized as sham acupuncture. The primary outcome measure is the 7-day voiding diary and the secondary outcome measures are urine nerve growth factor (NGF) level, the Incontinence Impact Questionnaire (IIQ-7), Urogenital Distress Inventory (UDI-6) and OAB Symptom Score (OABSS). All outcome measures will be collected at baseline, the end of treatment and 3 months after treatment completion.

Discussion

The objectives of this study include (1) to evaluate the effectiveness and safety of acupuncture treatment in patients with OAB on reduction in the frequency of incontinence episodes as derived from a 7-day voiding diary, (2) to evaluate whether acupuncture treatment could improve subjective symptoms in patients with OAB and (3) to examine the feasibility of using NGF as a biomarker for overactive bladder and test correlation with the effectiveness of acupuncture intervention. The finding of this study will provide preliminary evidence on the effectiveness and safety of acupuncture for treatment of OAB.

Trial registration

Chinese Clinical Trial Registry, ChiCTR-INR-16010048. Registered on 29 Nov 2016.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60(5 Suppl 1):7–12.CrossRefPubMed Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60(5 Suppl 1):7–12.CrossRefPubMed
2.
go back to reference Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol. 2005;106(1):138–42.CrossRefPubMed Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol. 2005;106(1):138–42.CrossRefPubMed
3.
go back to reference Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.PubMed Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.PubMed
5.
go back to reference Siu JYM. The illness experiences of women with overactive bladder in Hong Kong. Qual Health Res. 2014;24(6):801–2.CrossRefPubMed Siu JYM. The illness experiences of women with overactive bladder in Hong Kong. Qual Health Res. 2014;24(6):801–2.CrossRefPubMed
6.
go back to reference Wang LP, Wang LC, Shi GX, Zeng L, Yang Y, Zhang T, Liu H. Efficacy and safety of ginger-salt-indirect moxibustion for urge urinary incontinence after stroke: protocol for a pilot multicenter randomized controlled trial. BMJ Open. 2014;4:1–2. Wang LP, Wang LC, Shi GX, Zeng L, Yang Y, Zhang T, Liu H. Efficacy and safety of ginger-salt-indirect moxibustion for urge urinary incontinence after stroke: protocol for a pilot multicenter randomized controlled trial. BMJ Open. 2014;4:1–2.
8.
go back to reference Engberg S, Cohen S, Sereika SM. The efficacy of acupuncture in treating urge and mixed incontinence in women. J Wound Ostomy Continence Nurs. 2009;36(6):661–70.CrossRefPubMed Engberg S, Cohen S, Sereika SM. The efficacy of acupuncture in treating urge and mixed incontinence in women. J Wound Ostomy Continence Nurs. 2009;36(6):661–70.CrossRefPubMed
9.
go back to reference Kitakoji H, Terasaki T, Honjo H, Odahara Y, Ukimura O, Kojima M, Watanabe H. Effect of acupuncture on the overactive bladder. 日泌尿会誌. 1995;86(10):1514–9. Kitakoji H, Terasaki T, Honjo H, Odahara Y, Ukimura O, Kojima M, Watanabe H. Effect of acupuncture on the overactive bladder. 日泌尿会誌. 1995;86(10):1514–9.
10.
go back to reference Hartmann KE, McPheeters ML, Biller DH, Ward RM, McKoy JN, Jerome RN, Micucci SR, Meints L, Fisher JA, Scott TA, Slaughter JC, Blume JD. Treatment of Overactive Bladder in Women. Evidence Report/Technology Assessment. 2009;187:78–9. Hartmann KE, McPheeters ML, Biller DH, Ward RM, McKoy JN, Jerome RN, Micucci SR, Meints L, Fisher JA, Scott TA, Slaughter JC, Blume JD. Treatment of Overactive Bladder in Women. Evidence Report/Technology Assessment. 2009;187:78–9.
11.
go back to reference Irwin DE, Mungapen L, Milsom I, Kopp Z, Reeves P, Kelleher C. The economic impact of overactive bladder syndrome in six western countries. BJU Int. 2008;103:202–9.CrossRef Irwin DE, Mungapen L, Milsom I, Kopp Z, Reeves P, Kelleher C. The economic impact of overactive bladder syndrome in six western countries. BJU Int. 2008;103:202–9.CrossRef
12.
go back to reference Yuan ZY, He CX, Yan SB, Huang DL, Wang HH, Tang W. Acupuncture for overactive bladder in female adult: a randomized controlled trial. World J Urol. 2015;33(9):1303–8.CrossRefPubMed Yuan ZY, He CX, Yan SB, Huang DL, Wang HH, Tang W. Acupuncture for overactive bladder in female adult: a randomized controlled trial. World J Urol. 2015;33(9):1303–8.CrossRefPubMed
13.
go back to reference Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture-a review. Complement Ther Med. 2003;11(4):235–42.CrossRefPubMed Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture-a review. Complement Ther Med. 2003;11(4):235–42.CrossRefPubMed
14.
go back to reference Bergstrőma K, Carlssonb CPO, Lindholmc C, Widengrena R. Improvement of urge- and mixed-type incontinence after acupuncture treatment among elderly women — a pilot study. J Auton Nerv Syst. 2000;79:173–80.CrossRef Bergstrőma K, Carlssonb CPO, Lindholmc C, Widengrena R. Improvement of urge- and mixed-type incontinence after acupuncture treatment among elderly women — a pilot study. J Auton Nerv Syst. 2000;79:173–80.CrossRef
17.
go back to reference Park JB, White A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002;20(4):168–70.CrossRefPubMed Park JB, White A, Stevinson C, Ernst E, James M. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002;20(4):168–70.CrossRefPubMed
19.
go back to reference Aydogmus Y, Sunay M, Arslan H, Aydin A, Adiloglu AK, Sahin H. Acupuncture versus solifenacin for treatment of overactive bladder and its correlation with urine nerve growth factor levels: a randomized placebo-controlled clinical trial. Urol Int. 2014;93:437–43.CrossRefPubMed Aydogmus Y, Sunay M, Arslan H, Aydin A, Adiloglu AK, Sahin H. Acupuncture versus solifenacin for treatment of overactive bladder and its correlation with urine nerve growth factor levels: a randomized placebo-controlled clinical trial. Urol Int. 2014;93:437–43.CrossRefPubMed
20.
go back to reference Xian YF, Mao QQ, JCY W, Su ZR, Chen JN, Lai XP, Ip SP, Lin ZX. Isorhynchophylline treatment improves the Aβ-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. J Alzheimers Dis. 2014;39(2):331–46.CrossRefPubMed Xian YF, Mao QQ, JCY W, Su ZR, Chen JN, Lai XP, Ip SP, Lin ZX. Isorhynchophylline treatment improves the Aβ-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. J Alzheimers Dis. 2014;39(2):331–46.CrossRefPubMed
21.
go back to reference Mattiasson A, Djurhuus JC, Fonda D, Lose G, Nordling J, Stöhrer M. Standardization of outcome studies in patients with lower urinary tract dysfunction: a report on general principles from the standardisation Committee of the International Continence Society. Neurourol Urodyn. 1998;17:249–53.CrossRefPubMed Mattiasson A, Djurhuus JC, Fonda D, Lose G, Nordling J, Stöhrer M. Standardization of outcome studies in patients with lower urinary tract dysfunction: a report on general principles from the standardisation Committee of the International Continence Society. Neurourol Urodyn. 1998;17:249–53.CrossRefPubMed
22.
go back to reference Chan SSC, Choy KW, Lee BPY, Pang SMW, Yip SK, Lee LLL, Cheung RYK, Yiu AKW, Chung TKH. Chinese validation of urogenital distress inventory and incontinence impact questionnaire short form. Int Urogynecol J. 2010;21:807–12.CrossRefPubMed Chan SSC, Choy KW, Lee BPY, Pang SMW, Yip SK, Lee LLL, Cheung RYK, Yiu AKW, Chung TKH. Chinese validation of urogenital distress inventory and incontinence impact questionnaire short form. Int Urogynecol J. 2010;21:807–12.CrossRefPubMed
23.
go back to reference Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology. 2006;68(2):318–23.CrossRefPubMed Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology. 2006;68(2):318–23.CrossRefPubMed
24.
go back to reference Seth JH, Sahai A, Khan MS, van der Aa F, de Ridder D, Panicker JN, Dasgupta P, Fowler CJ. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? BJU Int. 2013;111:372–80.CrossRefPubMed Seth JH, Sahai A, Khan MS, van der Aa F, de Ridder D, Panicker JN, Dasgupta P, Fowler CJ. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? BJU Int. 2013;111:372–80.CrossRefPubMed
25.
go back to reference Kuo HC, Liu HT, Chancellor MB. Can urinary nerve growth factor be a biomarker for overactive bladder? Rev Urol. 2010;12(2/3):e69–77.PubMedPubMedCentral Kuo HC, Liu HT, Chancellor MB. Can urinary nerve growth factor be a biomarker for overactive bladder? Rev Urol. 2010;12(2/3):e69–77.PubMedPubMedCentral
26.
go back to reference Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica. 2015;38(6):506–14. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica. 2015;38(6):506–14.
Metadata
Title
Effectiveness and safety of acupuncture for elderly overactive bladder population in Hong Kong: study protocol for a randomized controlled trial
Authors
Yu Tat Chan
Hong Wei Zhang
Yuan Qi Guo
Tony Ngai Ho Chan
Yiu-Keung Kwan
Chun-Kam Lee
Kit Ngan
Zhi-Xiu Lin
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2706-4

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue